Malte Peters - 03 Nov 2025 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role: Director
Signature: /s/ Daniella Beckman, as attorney-in-fact
Issuer symbol: TNGX
Transactions as of: 03 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Nov 2025, 09:25:50 UTC
Previous filing: 09 Oct 2025
Next filing: 12 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Peters Malte	Director	C/O TANGO THERAPEUTICS, INC, 201 BROOKLINE AVE., SUITE 901, BOSTON	/s/ Daniella Beckman, as attorney-in-fact	04 Nov 2025	0001876563

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNGX	Stock Option (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	03 Nov 2025	Common Stock	150,000	$8.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option shall vest and become exercisable in 48 substantially equal monthly installments over a period of four years, with the first vesting date on December 3, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.